Vinita Kothari
Family · Los Alamitos, CANPI 1417428731
Payments from drug & device makers
Across 75 payments — averaging $85.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Vanda Pharmaceuticals Inc.$494
- GSK$348
- Abiomed$253
- Teva Pharmaceuticals USA, Inc.$252
- Alnylam Pharmaceuticals Inc.$244
- plus $4K from 27 others
What the payments were for
- Food & beverage$6,389100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 28 | $1,064 |
| Vanda Pharmaceuticals Inc. | 4 | $494 |
| GSK | 3 | $348 |
| Abiomed | 2 | $253 |
| Teva Pharmaceuticals USA, Inc. | 2 | $252 |
| Alnylam Pharmaceuticals Inc. | 2 | $244 |
| Argenx US, Inc. | 2 | $241 |
| Axsome Therapeutics, Inc. | 2 | $241 |
| Amgen | 2 | $239 |
| Neurocrine Biosciences, Inc. | 2 | $236 |
| Ultragenyx Pharmaceutical Inc. | 2 | $227 |
| Biogen | 2 | $208 |
| Cvrx, Inc. | 1 | $151 |
| Sanofi | 1 | $149 |
| Boston Scientific | 2 | $143 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $130 |
| AstraZeneca | 1 | $125 |
| Edwards Lifesciences | 1 | $125 |
| Neurelis, Inc. | 1 | $125 |
| AMAG Pharmaceuticals, Inc. | 1 | $125 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $125 |
| Amylyx Pharmaceuticals, Inc. | 1 | $122 |
| Otsuka America Pharmaceutical, Inc. | 1 | $120 |
| Astellas Pharma US Inc | 1 | $118 |
| Boehringer Ingelheim | 1 | $117 |
| Tactile Systems Technology Inc | 1 | $107 |
| Johnson & Johnson | 1 | $106 |
| Gilead | 1 | $90 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $89 |
| Alkermes, Inc. | 1 | $88 |
| Gen-probe Sales & Service, Inc. | 1 | $86 |
| Stryker | 1 | $77 |
| TG Therapeutics, Inc. | 1 | $22 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$6,389 in reported general payments places this provider in the 95th percentile of 10,634 family providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 27 | $259 |
| Doxycycline Monohydrate | 20 | $195 |
| Paxlovid (Eua)Nirmatrelvir/Ritonavir | 11 | $187 |
| Prednisone | 15 | $127 |
| PaxlovidNirmatrelvir/Ritonavir | 26 | $0 |
Paid to pharmacies, not to this prescriber.
Other family in Los Alamitos
- Lori RobertsonChino Hills$475K
- Annette ShonLos Angeles$406K
- Nancy GardettoSan Diego$394K
- Lisa HigginsHanford$311K
- Jennifer TougasBakersfield$302K
- Kim SchaferSacramento$288K
- Dawn MeyerSan Diego$270K
- Jennifer KangCerritos$255K
- Jenine StoneEscondido$231K
- Erin DwyerSan Diego$189K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.